• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与高血浆左旋多巴相关的“开-关”现象。

"On-off" phenomena related to high plasma levodopa.

作者信息

Claveria L E, Calne D B, Allen J G

出版信息

Br Med J. 1973 Jun 16;2(5867):641-3. doi: 10.1136/bmj.2.5867.641.

DOI:10.1136/bmj.2.5867.641
PMID:4714848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1589642/
Abstract

The neurological deficit and plasma concentrations of levodopa have been studied in a Parkinsonian patient experiencing "on-off" phenomena. Blind evaluations of transient attacks of dysphonia revealed an association between episodes of neurological deterioration and exceptionally high plasma concentrations of levodopa shortly after ingestion. These results indicate that "on-off" phenomena can be toxic reactions to levodopa rather than deteriorations due to inadequate intake or absorption of the drug. Management of patients subject to such attacks should be aimed at minimizing fluctuations in the serum level of the drug.

摘要

对一名出现“开-关”现象的帕金森病患者的神经功能缺损和左旋多巴血浆浓度进行了研究。对短暂性发音障碍发作的盲法评估显示,神经功能恶化发作与摄入后不久血浆中左旋多巴异常高浓度之间存在关联。这些结果表明,“开-关”现象可能是对左旋多巴的毒性反应,而非药物摄入不足或吸收不良导致的病情恶化。对遭受此类发作的患者进行管理应旨在尽量减少药物血清水平的波动。

相似文献

1
"On-off" phenomena related to high plasma levodopa.与高血浆左旋多巴相关的“开-关”现象。
Br Med J. 1973 Jun 16;2(5867):641-3. doi: 10.1136/bmj.2.5867.641.
2
Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim.帕金森病中左旋多巴血浆浓度与临床反应的关系。
Br J Pharmacol. 1971 Oct;43(2):464P-465P.
3
The effect of antacid administration on the absorption and metabolism of levodopa.抗酸剂给药对左旋多巴吸收和代谢的影响。
J Clin Pharmacol New Drugs. 1972 Jul;12(7):263-7. doi: 10.1002/j.1552-4604.1972.tb00053.x.
4
Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.左旋多巴吸收的变化。一例帕金森病患者在接受治疗剂量左旋多巴后血浆多巴浓度升高的报告。
Acta Med Scand. 1974 Dec;196(6):459-63.
5
Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances.左旋多巴治疗的帕金森病患者的色氨酸吸收不良。色氨酸对精神障碍的影响。
Acta Med Scand. 1973;194(3):181-9. doi: 10.1111/j.0954-6820.1973.tb19428.x.
6
Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.左旋多巴与其他药物的相互作用:在帕金森病治疗中的意义
Drugs. 1973;6(5):364-88. doi: 10.2165/00003495-197306050-00004.
7
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.苯海索、金刚烷胺和左旋多巴治疗帕金森病的对比试验。
J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):422-6. doi: 10.1136/jnnp.37.4.422.
8
Problems with long-term levodopa therapy for Parkinson's disease.帕金森病长期左旋多巴治疗的问题。
Clin Neuropharmacol. 1994;17 Suppl 2:S32-44.
9
Psychiatric side effects of levodopa in man.左旋多巴对人体的精神副作用。
JAMA. 1971 Dec 27;218(13):1915-20.
10
Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.帕金森综合征患者血浆多巴水平及对左旋多巴的生长激素反应
J Neurol Neurosurg Psychiatry. 1977 Feb;40(2):162-7. doi: 10.1136/jnnp.40.2.162.

引用本文的文献

1
The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism.帕金森病患者标准口服左旋多巴的吸收和代谢。
Br J Clin Pharmacol. 1974 Oct;1(5):417-24. doi: 10.1111/j.1365-2125.1974.tb00280.x.
2
Bromocriptine and dopamine receptor stimulation.溴隐亭和多巴胺受体刺激。
Br J Clin Pharmacol. 1976 Dec;3(6):977-82. doi: 10.1111/j.1365-2125.1976.tb00346.x.
3
Treatment of Parkinson's disease: problems with a progressing disease.帕金森病的治疗:进展性疾病的问题
J Neural Transm. 1981;51(1-2):161-74. doi: 10.1007/BF01664013.
4
Anti-parkinsonian drugs today.当今的抗帕金森病药物。
Drugs. 1984 Sep;28(3):236-62. doi: 10.2165/00003495-198428030-00002.
5
Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.大鼠口服(14C)-O-甲基多巴和(14C)-L-多巴后的吸收、代谢及分布
Br J Pharmacol. 1974 Feb;50(2):259-63. doi: 10.1111/j.1476-5381.1974.tb08570.x.
6
Clinical pharmacokinetics of levodopa in parkinson's disease.帕金森病中左旋多巴的临床药代动力学
Clin Pharmacokinet. 1976;1(5):313-38. doi: 10.2165/00003088-197601050-00001.

本文引用的文献

1
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.用脑外脱羧酶抑制剂与左旋多巴联合治疗特发性帕金森病。
Br Med J. 1971 Sep 25;3(5777):729-32. doi: 10.1136/bmj.3.5777.729.
2
Treatment of Parkinson's disease with levodopa and Ro 4-4602.左旋多巴和Ro 4-4602治疗帕金森病
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):353-9. doi: 10.1002/cpt1971122part2353.
3
Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
J Neurol Sci. 1972 Sep;17(1):45-51. doi: 10.1016/0022-510x(72)90021-4.
4
Modification of Parkinsonism--chronic treatment with L-dopa.帕金森病的改善——左旋多巴的长期治疗
N Engl J Med. 1969 Feb 13;280(7):337-45. doi: 10.1056/NEJM196902132800701.